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The effect of Emdogain on
the growth and
differentiation of rat bone
marrow cells
J. van den Dolder, A. P. G. Vloon,
J. A. Jansen
Department of Periodontology and Biomaterials,
Radboud University Nijmegen Medical Center,
Nijmegen, the Netherlands
A strategy to enhance the osteogenic
capability of a bone graft substitute is
the use of a scaﬀold material loaded
with bone-inductive growth factors
prior to implantation. These growth
factors are released at the implant site
and act upon existing cells or recruit
other cells to form new bone tissue.
However, there is another group of
proteins that can support and enhance
bone formation, namely extracellular
(enamel) matrix proteins. Extracellu-
lar matrix (ECM) is produced by os-
teoblasts and consists of several
classes of molecules that regulate
modeling and remodeling of bone.
ECM contains structural proteins that
serve multiple roles in bone forma-
tion, ranging from cell attachment
(e.g. ﬁbronectin, collagen type I, os-
teopontin and bone sialoprotein) to
nucleators for mineralization (e.g. os-
teopontin and bone sialoprotein)
(1,2). Teeth diﬀer from other skeletal
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Background and Objective: The major extracellular matrix (ECM) proteins in
developing enamel can induce and maintain the formation and mineralization of
other skeletal hard tissue, such as bone. Therefore, dental matrix proteins are ideal
therapeutic agents when direct formation of functional bone is required for a
successful clinical outcome. Emdogain (EMD) consists of enamel matrix pro-
teins which are known to stimulate bone formation. However, only a few studies in
the literature have reported the eﬀect of EMD on osteoblast-like cells in vitro.
Material and Methods: In this study, rat bone marrow cells, obtained from the
femora of Wistar rats, were precultured for 7 d in osteogenic medium. Then, the
cells were harvested and seeded in 24-well plates at a concentration of 20,000 cells/
well. The wells were either precoated with 100 lg/ml EMD, or left uncoated. The
seeded cells were cultured in osteogenic medium for 32 d and analysed for cell
attachment (by using the Live and Dead assay), cell growth (by determining DNA
content) and cell diﬀerentiation (by measuring alkaline phosphatase activity and
calcium content, and by using scanning electron microscopy and the reverse
transcription–polymerase chain reaction).
Results: The results showed that at the 4-h time point of the experiment, more
cells were attached to EMD-negative wells, but this eﬀect was no longer apparent
at 24 h. DNA analysis revealed that both groups showed a similar linear trend of
cell growth. No diﬀerences in alkaline phosphatase activity or calcium content
were observed, and no diﬀerences in gene expression (osteocalcin, alkaline phos-
phatase and collagen type I) were found between the groups.
Conclusion: Based on our results, we conclude that EMD had no signiﬁcant eﬀect
on the cell growth and diﬀerentiation of rat bone marrow cells.
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tissues in that they are more highly
mineralized and more resistant to
mechanical, chemical and biological
breakdown. Dental matrix proteins
produced by ameloblasts are also
inducers for the mineralization of
bony tissues. From literature reports
it is known that the major ECM
proteins in developing enamel can in-
duce and maintain the formation and
mineralization of other skeletal hard
tissue, such as bone. Therefore, dental
matrix proteins are ideal therapeutic
agents where the direct formation of
functional bone is required for a suc-
cessful clinical outcome (3–6).
A puriﬁed enamel matrix protein
product, Emdogain (EMD), has been
introduced commercially. EMD is pre-
pared from developing porcine teeth
and consists mainly of amelogenin and
some undetectable growth factors (7).
Amelogenins are hydrophobic proteins
that are known to self-assemble into
supramolecular aggregates which form
an insoluble extracellular matrix (8)
with high aﬃnity for hydroxyapatite
and collagens (9). Animal experiments
and clinical studies of periodontal
treatment have already demonstrated
that EMD stimulates the regeneration
of periodontal tissue, including acellu-
lar cementum, periodontal ligament
(PDL) cells and alveolar bone (10–14).
The eﬀect of EMD on PDL cells in vitro
has been examined in diﬀerent studies,
which found that EMD stimulates cel-
lular proliferation, alkaline phospha-
tase (ALP) activity, mineralized nodule
formation and transforming growth
factor-b1 (TGF-b1) production
(9,15,16). However, only a few studies
have reported the eﬀect of EMD on
osteoblast-like cells or bone marrow
cells. Yoneda et al. (17) used two
mouse osteoblastic cell lines and
showed that the eﬀect of EMDwas cell-
type dependent. They found no eﬀect
for EMD with the ST2 cell line, but
with the KUSA/A1 cell line they ob-
served enhanced cell proliferation, ALP
activity and mineralized nodule for-
mation. Other studies also observed
diﬀerent responses of their osteoblastic
cell lines with EMD (18,19). Keila et al.
(20) performed a study with rat bone
marrow cells and observed an increase
in the osteogenic capacity (ALP activity
and mineralized nodule formation) of
the cells in the presence of EMD.
Therefore, the aim of the present
study was to evaluate the eﬀect of EMD
on the proliferation and diﬀerentiation
of rat bone marrow cells.
Material and methods
Cell isolation
Rat bonemarrow (RBM) cells were iso-
lated and culturedusing themethoddes-
cribed by Maniatopoulos (21). Femora
of male Wistar rats were washed in a-
minimalessentialmedium(MEM;Gibco
BRL, Life Technologies B.V. Breda, the
Netherlands) containing 0.5 mg/ml
gentamycin and 3 lg/ml fungizone (Sig-
ma Chemical Co., St Louis,MO,USA).
Epiphyses were cut oﬀ and diaphyses
ﬂushed out with 15 ml of a-MEM sup-
plemented with 10% foetal calf serum
(FCS) (Gibco BRL, Life Technologies),
50 lg/ml ascorbic acid, 50 lg/ml genta-
mycin, 10 mM sodium b-glycerophos-
phate and 10)8 M dexamethasone
(Sigma Chemical Co.). The cells were
incubated in a humidiﬁed atmosphere
of 95% air, 5% CO2, at 37C for 7 d.
The medium was changed every 2–3 d.
Cell seeding
After 7 d of primary culture, cells were
seeded as a cell suspension (20,000 cells/
well) in 24-well plates or on Therman-
ox discs (Nalge Nunc Int., Naperville,
IL, USA). However, before seeding,
half of the 24-well plates or Therman-
ox discs were ﬁrst coated with 100 lg/
ml EMD (Straumann AG, Walden-
burg, Switserland). Cells were cultured
in the presence of osteogenic medium
(a-MEM, supplemented with 10%
FCS) containing 50 lg/ml ascorbic
acid, 50 lg/ml gentamycin, 10 mM so-
dium b-glycerophosphate and 10)8 M
dexamethasone (Sigma Chemical Co.)
and incubated in a humidiﬁed atmo-
sphere of 95% air, 5% CO2, at 37C.
The medium was changed every 2–3 d.
Cell attachment and spreading
After an incubation period of 1, 4, 8 or
24 h, cells were evaluated on their
attachment and spreading. The Live
and Dead viability assay (Molecular
Probes, Leiden, the Netherlands) was
performed on the cells, and consisted of
washing with phosphate-buﬀered saline
(PBS), covering with substance A
(1.0 ll) and B (3.5 ll), incubation for
30–45 min at 37C, washing with PBS,
and ﬁnally analysis under the ﬂuores-
cence microscope. Green cells were vi-
able cells, where red cells were not.
DNA analysis
After 1, 2, 4, 8 or 12 d of incubation,
samples were used for DNA analysis.
Medium was removed and the cell
layers were washed twice with PBS.
One millilitre of MilliQ was added to
each sample. The samples were frozen
and thawed repeatedly.
A DNA standard curve was made
with Lambda DNA. One-hundred
microlitres of sample or standard was
added to 100 ll of Picogreen working
solution (Molecular Probes) and the
samples were incubated for 10 min at
room temperature in the dark. After
incubation, DNA was measured using
a ﬂuorescence microplate reader with
excitation ﬁlter 365 nm and emission
ﬁlter 450 nm. The same samples were
also used for the ALP activity assay.
ALP activity
ALPactivitywasmeasuredondays2,4,8
and 12 of incubation. For the assay
(Sigma Chemical Co.), 96-well plates
were used. Eighty microlitres of sample
and 20 ll of buﬀer solution (5 mM
MgCl2, 0.5 M 2-amino-2-methyl-1-pro-
panol) were added to the wells. Subse-
quently, 100 ll of substrate solution
(5 mM paranitrophenylphosphate) was
added to the wells and the plate was
incubated for 1 h at 37C. The reaction
was stopped by adding 100 ll of stop
solution (0.3 M NaOH). For the stand-
ard curve, serial dilutions of 4-nitrophe-
nol were added to ﬁnal concentrations
of 0–25 nM. The plate was read in an
enzyme-linked immunosorbent assay
(ELISA) reader at 405 nm.
Calcium content
The calcium content in the samples was
measured by the ortho-cresolphthalein
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complexone (OCPC) method (Sigma
Chemical Co.). The calcium content
was examined on days 8, 16, 24 and 32
of incubation. Cell layers were washed
twice in PBS. Five-hundred microlitres
of 0.5 N acetic acid was added to the
wells and the samples were incubated
overnight. Samples were frozen at
)20C until use.
OCPC solution was prepared as
follows: 80 mg of OCPC was added to
75 ml of demineralized H2O together
with 0.5 ml of 1 M KOH and 0.5 ml
of 0.5 N acetic acid. To prepare
sample solution, 5 ml of OCPC solu-
tion was added to 5 ml of 14.8 M
ethanolamine/boric acid buﬀer
(pH 11), 2 ml of 8-hydroxyquinoline
(5 g in 100 ml of 95% ethanol) and
88 ml of demineralized water. Three-
hundred microlitres of sample solution
was added to 10 ll of sample. To
generate a standard curve, serial dilu-
tions of CaCl2 were made (1–200 lg/
ml). The plate was incubated at room
temperature for 10 min then read at
575 nm.
Scanning electron microscopy (SEM)
After days 8 and 24 of incubation,
Thermanox discs seeded with cells
were washed twice with PBS. Fixation
was carried out for 10 min in 2% glu-
taraldehyde, then the substrates were
washed twice with 0.1 M sodium-caco-
dylate buﬀer (pH 7.4), dehydrated in a
graded series of ethanol and dried by
tetramethylsilane (Sigma Chemical
Co.). The specimens were sputter-coa-
ted with gold, and examined and pho-
tographed using a Jeol 6310 scanning
electron microscope (JEOL (Europe)
B.V., Nieuw, Vennep, the Netherlands)
at an acceleration voltage of 10 kV.
SEM was performed at the Micro-
scopic Imaging Centre (MIC) of the
Nijmegen Centre for Molecular Life
Sciences (NCMLS), the Netherlands.
RNA isolation
RNA was isolated from the cells of six
wells of each group (with or without
EMD) with the aid of an RNA-isola-
tion kit (RNeasy kit; Qiagen, Venlo,
the Netherlands). The RNA obtained
from six wells was pooled to retrieve
suﬃcient RNA for analysis. Cells were
pelleted at 300 g in a tube and the
supernatant was removed. The cells
were then disrupted by adding 350 ll
of RLT lysis buﬀer. The samples were
stored at )70C until use.
The volume of the sample was dou-
bled by adding 70% ethanol and then
mixed by pipetting. Seven-hundred
microlitres of the samples were added
to an RNeasy mini column that was
placed in a collection tube. This was
centrifuged for 15 s at 3 g and the ﬂow-
through was discarded. Seven-hundred
microlitres of wash buﬀer RW1 was
added to the RNeasy columns. The
columns were then centrifuged for 15 s
at 3 g and the ﬂow-through was dis-
carded. Then, the column was trans-
ferred to a new 2-ml collection tube,
and 500 ll of RPE buﬀer diluted ﬁve-
fold was added to the columns. These
columns were again centrifuged for
15 s at 3 g and the ﬂow-through was
discarded. The columns were washed
again with 500 ll of diluted RPE buf-
fer, centrifuged for 2 min at 3 g and
the ﬂow-through was discarded.
Finally, the columns were transferred
to a new 1.5-ml tube and 40 ll of
RNase-free water was added directly
onto the RNeasy membrane in the
columns. The columns were centri-
fuged for 1 min at 3 g for RNA elu-
tion. The RNA obtained was
quantiﬁed by adding 1 ll of sample to
49 ll of RNase-free water and the
absorbance was measured in a spec-
trophotometer (Bio-Rad Laboratories,
Veenendaal, the Netherlands) at
260 nm.
Reverse transcription–polymerase
chain reaction (RT–PCR)
After isolation of the RNA, the RT
reaction was performed. One micro-
gram of total RNA, 1 ll of 100 ng of
random primers, 1 ll of dNTP mix
(10 mM each) and 10 ll of distilled
water were added to a nuclease-free
microcentrifuge tube. The mixture was
heated to 65C for 5 min and quickly
chilled on ice. The contents of the tube
were collected by brief centrifugation.
One microlitre of 5· First-Strand Buf-
fer (250 mM Tris-HCl, pH 8.3, 375 mM
KCl, 15 mM MgCl2) and 2 ll of 0.1 M
dithiothreitol (DTT) were added. This
was incubated at 25C for 10 min, and
the contents of the tube were mixed
gently and incubated at 42C for
2 min. Finally, 1 ll (200 U) of Super-
script II (Invitrogen, Breda, the Neth-
erlands) was added and incubated at
42C for 50 min. The reaction was
inactivated by heating the mixture at
70C for 15 min. The cDNA thus ob-
tained was used as a template in the
PCR.
Semiquantitative PCR
Five microlitres of 10· PCR Buﬀer
(200 mM Tris-HCl, pH 8.4, 500 mM
KCl), 1.5 ll of 50 mM MgCl2, 1 ll of
10 mM dNTP Mix, 1 ll of Ampliﬁca-
tion Primer 1 (10 lM), 1 ll of Ampli-
ﬁcation Primer 2 (10 lM), 0.2–0.5 ll of
Taq DNA polymerase (2–5 U/ml)
(Invitrogen), 1 lg of cDNA, and
autoclaved, distilled water, were added
to a PCR reaction tube to achieve a
ﬁnal volume of 50 ll. The following
genes were analysed: osteocalcin as a
late-diﬀerentiation marker, collagen
type I as a marker for the extracellular
matrix, and ALP as an early diﬀeren-
tiation marker. All data were normal-
ized to the housekeeping gene, b-actin.
Statistical analysis
This study was performed by using two
separate runs of experiments. In each
run, samples were present in triplicate.
In the results section, the data of both
runs are described, but only the ﬁrst
run is presented in the Figures. Statis-
tical analysis was performed for each
run by using an unpaired t-test
(GraphPad Software, Inc., San Diego,
CA, USA).
Results
In this study, a heterogenous cell pop-
ulation was obtained from bone mar-
row. As a result of this heterogeneity,
diﬀerences can exist between various
experimental runs, and, in this study,
discrepancies between the diﬀerent
runs were indeed observed.
The results of the Live and Dead
assay revealed that after 4 h, more cells
were attached to the noncoated surfa-
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ces than to the EMD-coated surfaces.
However, this diﬀerence was not ob-
served at 24 h. During the ﬁrst hours
of incubation, cells were not spread
and had a round shape, but after 24 h,
the cells were observed to spread more.
DNA analysis conﬁrmed the results
of the Live and Dead assay, namely
that equal numbers of cells were at-
tached to EMD-coated and noncoated
wells on day 1. Furthermore, DNA
analysis revealed no diﬀerences in cell
proliferation between the noncoated
and EMD-coated groups. Both
experimental runs showed a similar
linear cell growth with the same
amount of DNA (Fig. 1).
The ALP activity was higher in the
second run and had a peak on day 12.
The ﬁrst run had a peak on day 8. No
diﬀerences in ALP activity were ob-
served between the noncoated and
EMD-coated groups (Fig. 2).
The ﬁrst run of the calcium meas-
urements showed that the EMD-coa-
ted group had a signiﬁcantly enhanced
calcium content compared with the
uncoated cells on day 32 (p < 0.01).
Unfortunately, this diﬀerence was not
observed in the second run (Fig. 3).
SEM examination of both groups
indicated that cells did proliferate. On
day 8, multilayers of cells were already
evident. However, no diﬀerences
between noncoated and EMD-coated
specimens were observed. After 24 d of
incubation, a layer of calciﬁed globular
accretions, associated with collagen
bundles, was deposited on the speci-
mens. No clear diﬀerences in appear-
ance between the noncoated and
EMD-coated specimens were visible
(Fig. 4).
Furthermore, a semiquantitative
PCR analysis was performed on both
groups. Unfortunately, no clear diﬀer-
ences in the gene expression of ALP,
collagen type I and osteocalcin were
observed. However, a trend was seen in
favor of EMD. In addition, all the
genes were expressed and normalized
to the household gene, b-actin (Fig. 5).
Discussion
In the present study, the eﬀect of EMD
on the proliferation and diﬀerentiation
of rat bone marrow cells was exam-
ined. Unfortunately, no consistent
eﬀect of EMD on cell growth or dif-
ferentiation was observed in this
heterologous primary cell culture.
Calcium measurements showed a sig-
niﬁcant stimulatory eﬀect on matrix
mineralization of EMD in the ﬁrst run,
but not in the second run. Also, the
results of the PCR showed only a lim-
ited trend for increased expression of
the osteogenic genes ALP and osteo-
calcin. However, the PCR method used
was semiquantitative and, as a conse-
quence, strong conclusions cannot be
made.
From previous studies, we know
that the eﬀect of EMD on proliferation
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Fig. 2. The alkaline phosphatase (ALP)
activity of rat bone marrow cells cultured on
Emdogain (EMD)-coated (EMD plus)
and EMD-noncoated (EMD min) (ﬁrst run)
wells. Bars represent the standard deviation
(SD).
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marrow cells cultured on Emdogain
(EMD)-coated (EMD plus) and EMD-
noncoated (EMDmin) (ﬁrst run) wells. Bars
represent the standard deviation (SD).
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Fig. 4. Scanning electron micrographs of
day 8 (A) and day 24 (B).
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Fig. 1. The cell growth of rat bone marrow
cells cultured on Emdogain (EMD)-coa-
ted (EMD plus) and EMD-noncoated
(EMD min) (ﬁrst run) wells. Bars represent
the standard deviation (SD).
0.4
0.5
0.6
0.7
0.8
0.9
1
EMDmin
OC
EMDplus
OC
EMDmin
ALP
EMDplus
ALP
EMDmin
ColI
EMDplus
ColI
G
en
e 
ex
pr
es
si
on
 
n
o
rm
al
iz
ed
 b
y 
be
ta
-a
ct
in
A
B
Fig. 5. Results of semiquantitative polym-
erase chain reaction (PCR). (A) Gene
expression bands of a-actin (Actin), osteo-
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tative values of gene expression normalized
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and diﬀerentiation varies among dif-
ferent cell types, and the eﬀect of EMD
on diﬀerent osteoblastic cell lines has
been reported. Yoneda et al. (17)
reported that EMD stimulated KUSA/
A1 cell proliferation, although it did
not aﬀect ST2 cell proliferation. EMD
stimulated the ALP activity and min-
eralized nodule formation of KUSA/
A1 cells, but did not aﬀect the osteo-
blastic diﬀerentiation of ST2 cells.
Keila et al. (20) reported that bone
marrow stromal cells were stimulated
by EMD in their osteoblastic diﬀeren-
tiation by enhanced ALP activity and
mineralized nodule formation. The
growth of murine calvarial osteoblasts
was stimulated by the addition of
EMD (19). Schwartz et al. (18) found
that EMD stimulated the proliferation,
but not the diﬀerentiation, of preoste-
oblastic 2T9 cells, and inhibited the
proliferation and stimulated diﬀerenti-
ation of osteoblast-like MG63 cells.
They also found that the proliferation
and diﬀerentiation of normal human
osteoblast NHOst cells increased.
However, in agreement with our
observations, Gurpinar et al. (22)
revealed that EMD had no impact on
the cell growth of rat marrow stromal
osteoblasts.
In addition to cell type, most studies
diﬀer in cell source. Some researchers
used calvarial cells (19) to examine the
osteogenic capacity, while others used
bone marrow cells (20). Moreover,
diﬀerent types of rats were used for cell
retrieval [i.e. Wistar (the present study)
and Sprague-Dawley (20)]. All these
discrepancies in primary conditions
can have severe implications for the
ﬁnal results.
Besides diﬀerences in cell types,
variation in experimental designs may
also be responsible for inconsistences
in results between diﬀerent studies. For
example, in the present study we coa-
ted the 24-well plates with EMD, while
other studies used diluted EMD in
their medium (20). Furthermore, var-
ious concentrations of EMD were used
in diﬀerent studies. Some studies
reported that 100 lg/ml EMD is the
optimal concentration for stimulating
the osteogenic potential of PDL cells,
while others (20) reported that 25 lg/
ml EMD stimulated the osteogenic
potential of bone marrow stromal cells.
When 100 lg/ml EMD was used, no
diﬀerence between control and 100 lg/
ml EMD in ALP activity and matrix
mineralization was observed. In cons-
trast, Jiang et al. (19) observed that
EMD gave an enhanced response on
the growth of primary osteoblasts
digested from mouse calvaria with a
higher concentration of EMD (100 lg/
ml) compared with a lower concentra-
tion (25 lg/ml).
In this study, the 24-well plates were
ﬁrst coated with 100 lg/ml EMD be-
fore cells were added to the wells.
Freeze-dried EMD was diluted in 0.1%
acetic acid. We observed that the
hydrophobic enamel matrix proteins
aggregated at the bottom. This has
been mentioned by previous research-
ers and also observed when EMD was
diluted in culture media at neutral pH
(9,16,17). Jiang et al. (19) and Yoneda
et al. (17) diluted EMD in culture
media and found that EMD had an
enhancing eﬀect on osteoblastic cells.
Therefore, we believe that diluting
EMD in culture medium can give a
more predictable result than using
EMD as a coating.
The EMD product has been extrac-
ted from porcine tooth germs. There-
fore, osteoinductive factors may be
present in the extract. However,
Gestrelius et al. (7) used diﬀerent im-
munoassays to examine whether cer-
tain factors were present. Granulocyte–
macrophage colony-stimulating factor
(GM-CSF), calbindin D, epithelial
growth factor (EGF), ﬁbronectin, basic
ﬁbroblast growth factor (bFGF), a-
interferon, interleukin-1a, -2, -3 and -6,
insulin growth factor-1 (IGF-1) and -2,
neurotrophic growth factor (NGF),
platelet-derived growth factor (PDGF),
tumour necrosis factor (TNF) and
TGF-a were examined and none was
detected. Suzuki et al. (22) detected
bone sialoprotein (BSP) in EMD. BSP
is known to play an important role in
the mineralization of hard tissues as
well as in tooth development (23).
Furthermore, it is known that PDL
cells secrete, under the inﬂuence of
EMD, several growth factors, such as
TGF-a1, interleukin-6 and PDGF-AB
(16,24). Some studies of TGF-a1
showed enhanced cell proliferation
with bone marrow stromal cells, but no
enhancement in osteogenic diﬀerenti-
ation (25–27), while others found sti-
mulation of ALP activity with TGF-a1
(28,29).
Several in vivo experiments have
demonstrated that EMD stimulates
alveolar bone regeneration (6,13,14)
and regeneration of a femoral bone
defect (5), but ectopic studies revealed
no osteoinductivity (17). Based on our
results, and on the results of other
research groups, it is still unclear how
EMD exerts its function. Some claim
that EMD has mainly an angiogenic
eﬀect, which probably contributes to
the acceleration of wound healing and
bone regeneration (30). Others claim
that EMD maintains the viability of
adherent stromal cells and promotes
their osteogenic potential (20). How-
ever, such an eﬀect was not conﬁrmed
by our current RBM cell culture study.
Therefore, we conclude that EMD,
applied as a coating on a tissue culture
polystyrene substrate surface, has no
evident eﬀect on the proliferation and
diﬀerentiation of rat bone marrow
cells.
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